Following gene therapy, levels of T, B and natural
killer cells rose to near normal levels in five of the first six patients who enrolled in the study.
The progressive loss of diversity in the body's corps of
killer T -
cells as a result of immunological «crowding» is one of two reasons for our
rising vulnerability to viruses and other pathogens during degenerative aging.